Actively Recruiting

Age: 18Years +
All Genders
NCT07271342

Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China

Led by Beijing Tiantan Hospital · Updated on 2026-01-06

10000

Participants Needed

1

Research Sites

186 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The ORIENTAL study is a prospective, multicenter, continuously enrolled real-world cohort designed to evaluate the effectiveness and safety of intravenous tenecteplase for acute ischemic stroke (AIS) in routine clinical practice across China. Approximately 10,000 patients from about 200 hospitals will be included. Eligible adults with imaging-confirmed AIS who receive tenecteplase as part of standard care will be consecutively enrolled and followed through 90 days. The study will describe patient characteristics, treatment processes, functional outcomes, and safety events, and will also explore inter-hospital variability and subgroup differences to support quality improvement and guide nationwide implementation of tenecteplase therapy.

CONDITIONS

Official Title

Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or older
  • Diagnosed with acute ischemic stroke confirmed by imaging (CT or MRI)
  • Treated with intravenous tenecteplase at the participating institution
  • Provided written informed consent, signed by the patient or their legally authorized representative
  • Capable of completing follow-up assessments
Not Eligible

You will not qualify if you...

  • Received reperfusion therapy prior to hospital admission (e.g., intravenous thrombolysis before admission)
  • Participating in any clinical trials where the intervention may affect this study's outcomes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Beijing Tiantan Hospital, Capital Medical University

Beijing, China, 100070

Actively Recruiting

Loading map...

Research Team

Y

Yongjun Wang, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here